Surrogate Mother Dies of Complications
By Times of India,
Times of India
| 05. 17. 2012
AHMEDABAD: Premila Vaghela, 30, had opted to become a surrogate mother and deliver child of a US-based couple to supplement her family income and brighten the future of her own two kids.
On Wednesday, Premila, who was eight months pregnant, died due to unexplained complications. But she completed her job - the child was delivered and is in the NICU recuperating from early birth.
Surrogacy has picked up majorly all over Gujarat where Anand is considered the global surrogacy capital. Ahmedabad too caters to a big number of couples who medically need a womb to carry their child. Couples are known to pay anywhere between Rs 2.5 lakh and Rs 4 lakh to women who offer their wombs on rent to conceive and deliver the child. The decent money offered by couples, majority of who are NRGs and foreigners, attracts many women from poor socio-economic backgrounds to offer themselves as surrogates.
Premila paid the price of offering herself as surrogate with her life. Dr Manish Banker of Pulse Hospital, where Premila was a surrogate, said that they are clueless as...
Related Articles
By John H. Evans, Craig Callender, Neal K. Devaraj, Farren J. Isaacs, and Gregory E. Kaebnick, Issues in Science and Technology | 07.04.2025
The controversy around a ban on “mirror life” should lead to a more nuanced public conversation about how to manage the benefits and risks of precursor biotechnologies.
About five years ago, the five of us formed a discussion group to...
By Annika Inampudi, Science | 07.10.2025
Before a baby in the United States reaches a few days old, doctors will run biochemical tests on a few drops of their blood to catch certain genetic diseases that need immediate care to prevent brain damage or other serious...
By Geoffrey A. Fowler, The Washington Post | 07.17.2025
Nearly 2 million people protected their privacy by deleting their DNA from 23andMe after it declared bankruptcy in March. Now it’s back with the same person in charge — and I still don’t trust it.
Nor do the attorneys general...
By Angus Liu, Fierce Pharma | 07.22.2025
A brief skirmish between Sarepta Therapeutics and the FDA has ended before escalating into a full-on regulatory clash, as the company has bowed to the agency’s demand.
In a surprising reversal, Sarepta on Monday said it will pause all shipments...